Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

HeartBeat.bio AG, corporate

HeartBeat.bio AG,

04.05.2021 - 10:03:10

HeartBeat.bio AG to Reinvent Cardiac Drug Discovery

or follow us on LinkedIn.

About IMBA IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences - is one of the leading biomedical research institutes in Europe focusing on cutting-edge stem cell technologies, functional genomics, and RNA biology. IMBA is located at the Vienna BioCenter, a vibrant cluster of universities, research institutes and biotech companies in Austria. IMBA is a subsidiary of the Austrian Academy of Sciences, the leading national sponsor of non-university academic research. The stem cell and organoid research at IMBA is being funded by the Austrian Federal Ministry of Science and the City of Vienna.

About red-stars.com data AG red-stars.com data AG is an operative holding company engaged in the global penetration of highly scalable innovative technologies, utilizing and commercializing scientific IP and software.

Contact:

HeartBeat.bio AG Vienna Biocenter 6, Dr. Bohr Gasse 7, A-1030 Vienna, Austria Michael Krebs, CEO Email: office@heartbeat.biowww.heartbeat.bio

IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences Vienna Biocenter 3, Dr. Bohr Gasse 3, A-1030 Vienna, Austria Lea-Louisa Klement, M.A., Scientific Office & Event Coordinator Phone: +43 1 79044 - 4804 Email: lea.klement@imba.oeaw.ac.atwww.imba.oeaw.ac.at

red-stars.com data AG Graben 14/B26, A-1010 Vienna, Austria Thomas Streimelweger, CEO Phone: +43 664 3402678 Email: t.streimelweger@red-stars.com www.red-stars.com

For Press Enquiries:

MC Services AG Julia von Hummel, Andreas Jungfer Phone: +49 89 210 228-0 Shaun Brown Phone: +44 20 71485998 Email: heartbeatbio@mc-services.eu

04.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: HeartBeat.bio AG Dr. Bohr Gasse 7 1030 Wien

Austria E-mail: office@heartbeat.bio Internet: https://heartbeat.bio/ EQS News ID: 1192262 ? End of News DGAP News Service

1192262??04.05.2021?

@ dgap.de